Incyte has announced encouraging top-line findings from its pivotal Phase III frontMIND trial, evaluating tafasitamab (marketed as Monjuvi/Minjuvi) in combination with lenalidomide and the standard
Researchers at Oregon Health & Science University have made a significant breakthrough in the fight against acute myeloid leukaemia (AML), discovering that combining a standard
I’ve always known that I wanted to help people. Growing up as the son of a veterinarian and a high school teacher who later became
Iowa University researchers at its Children’s Hospital led the effort that found a new target. According to the Iowa Carver College of Medicine, to date,
Editor’s Note: The following study results were first published in Nephrology Dialysis Transplantation (December 16, 2025) and later shared in the Oxford Academic. The original
Otsuka has claimed a significant victory in the increasingly competitive immunoglobulin A nephropathy (IgAN) field with FDA accelerated approval of Voyxact, the first-in-class anti-APRIL biologic
As reported on FiercePharma, Johnson & Johnson has secured a significant milestone in prostate cancer treatment with the FDA’s approval of Akeega for patients with
A groundbreaking study from Massachusetts General Hospital reveals that artificial intelligence is catching breast cancers that skilled radiologists initially overlook. As reported by Business Wire,
There’s a lot to consider when you’re facing tumor removal surgery. Think about mandible or jaw surgery, for example. Your face is part of every
As reported on PharmaBiz, GENESIS Pharma has announced an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL) to distribute and commercialize donidalorsen across 14 Central
As reported on PharmaBiz, Renalys Pharma has reported encouraging topline data from its Phase III trial evaluating sparsentan (RE-021), an oral dual endothelin and angiotensin
Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial on December 15, 2025 and reported by Drugs.com, marking a significant advancement in
As reported on BioPharmaDive, the U.S. Food and Drug Administration (FDA) has granted early approval for a new frontline treatment option for HER2-positive metastatic breast
A groundbreaking study published in Neurology and reported by Drugs.com reveals that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs),
I’m Nella, and this is part of my journey with Metabolic dysfunction-associated steatohepatitis (MASH). I was diagnosed with MASH in early 2024, after being
When we hear the word diet, most of us automatically think of food. But what about our thoughts? Let’s look at them in terms of
When life-threatening pustules suddenly erupt across the body accompanied by systemic inflammation, generalized pustular psoriasis (GPP) patients face a medical crisis with few treatment options.
Editor’s Note: This story share was submitted by Beverly Smith, a retired schoolteacher from Canada. I was diagnosed after treatment for PTSD and having had
Our friends at the Solution Project have shared upcoming research opportunities for Ataxia and other neurological movement disorders. If you're interested in learning more, read here!
patientworthy.com/2026/01/23/research-opportunities-in-ataxia-and-movement-disorders/
We're honored to share Erika's story of raising a child with Dravet syndrome, a rare form of epilepsy. Read here:
patientworthy.com/2026/01/23/choosing-joy-erikas-journey-of-raising-a-child-with-dravet-syndrome-...
Wondering how ADHD is diagnosed? There's no single test - diagnosis requires multiple assessments, clinical evaluation, and professional expertise. Swipe for what the process looks like and click here to share your experiences with us: bit.ly/4dV7gru
#adhd #attentiondeficithyperactivitydisorder #adhddiagnosis #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
